A Randomized, Open-label, Parallel Group, Multi-center Phase II Clinical Trial DCVAC/OvCa Added to Standard Chemotherapy in Women With Relapsed Platinum Sensitive Epithelial Ovarian Carcinoma
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2018
At a glance
- Drugs DCVAC OvCa (Primary) ; Carboplatin; Gemcitabine
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Sponsors SOTIO
- 05 Jun 2018 Results (n=71) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 03 Jun 2018 According to a SOTIO media release, data from this study was presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 18 Apr 2018 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History